Preclinical News and Research

RSS
Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

A minimally invasive approach to managing pain without opioids

A minimally invasive approach to managing pain without opioids

New animal model for COVID-19

New animal model for COVID-19

Three FDA-approved drugs can block the replication of COVID-19 virus

Three FDA-approved drugs can block the replication of COVID-19 virus

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Roswell Park team proposes possible new strategy for treating pancreatic cancer

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Boehringer Ingelheim acquires Northern Biologics to expand cancer immunology portfolio

Biologic drug can help treat contact dermatitis

Biologic drug can help treat contact dermatitis

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

Boehringer Ingelheim partners with CDR-Life to develop antibody fragment-based therapeutics for geographic atrophy

First detailed study of the epigenetic landscape of human tumor organoids

First detailed study of the epigenetic landscape of human tumor organoids

A road map to find unanswered questions about COVID-19

A road map to find unanswered questions about COVID-19

Molecular imaging can help identify treatment response in neuroendocrine tumor patients

Molecular imaging can help identify treatment response in neuroendocrine tumor patients

Ori Biotech and CellGenix to collaborate in order to promote innovation within closed-system cell and gene therapy manufacturing

Ori Biotech and CellGenix to collaborate in order to promote innovation within closed-system cell and gene therapy manufacturing

First detailed study of the epigenetic landscape of human tumor organoids

First detailed study of the epigenetic landscape of human tumor organoids

Vaccine design can face specific challenges, say researchers

Vaccine design can face specific challenges, say researchers

Innovative approach turns 'cold' tumors 'hot' to improve cancer immunotherapy

Innovative approach turns 'cold' tumors 'hot' to improve cancer immunotherapy

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

Sanford director receives major grant to advance broad-spectrum antivirals for respiratory diseases

Sanford director receives major grant to advance broad-spectrum antivirals for respiratory diseases

COVID-19 patients improve after experimental heart cell therapy

COVID-19 patients improve after experimental heart cell therapy

Study: New combination treatment significantly improves degenerative joint diseases

Study: New combination treatment significantly improves degenerative joint diseases

New two-in-one shot could make it easier for diabetics to control their blood sugar

New two-in-one shot could make it easier for diabetics to control their blood sugar

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.